In plain language
VIP (vasoactive intestinal peptide) is a natural signaling peptide with roles in blood-vessel dilation, gut function, and immune regulation. It is sometimes used off-label or compounded (for example as a nasal spray for chronic inflammatory conditions) and a synthetic form, aviptadil, has been investigated for lung conditions. Most specific therapeutic uses are not well established.
What it is explored for
VIP is a well-characterized natural signaling peptide with genuine roles in blood flow, gut function, and calming inflammation, which makes its biology interesting and real. The honest caveat is that evidence for its specific marketed and off-label protocols is limited and largely investigational. Here is where interest and reported use are concentrated.
- Healthy blood flow and vasodilation
- Immune and anti-inflammatory interest
- Chronic inflammatory illness research
- Airway and lung research
- Gut function and motility
These are areas of active interest and reported use, not proven outcomes. This peptide carries a preliminary evidence rating, see the evidence summary below for how strong the science actually is.
How it works
VIP is a widely distributed signaling peptide acting through VPAC receptors. Its biology is well known, but using it as a targeted therapy is largely investigational.
- Vasodilation and smooth muscle. Relaxes vascular and airway smooth muscle, which underlies interest in lung and circulatory applications.
- Immune and anti-inflammatory signaling. Modulates immune-cell activity and can reduce inflammation, relevant to its use claims in chronic inflammatory illness.
- Gut and neural roles. Functions as a neurotransmitter and regulator of gastrointestinal secretion and motility.
While VIP's physiology is well characterized, evidence for specific therapeutic protocols (such as nasal VIP for CIRS) is limited and largely investigational.
Evidence summary
VIP is a well-characterized natural peptide, but evidence for its specific marketed and off-label therapeutic uses is limited. Investigational forms like aviptadil have been studied for lung conditions with uncertain results, so therapeutic confidence remains preliminary.
Reported safety & side effects
Because VIP causes vasodilation, side effects such as flushing and low blood pressure are plausible, and compounded products vary in quality. Safety of specific protocols is not well established.
Frequently asked
Is VIP a natural substance?
Yes. It is an endogenous signaling peptide found throughout the body, involved in blood vessel, gut, and immune function.
Is nasal VIP a proven treatment?
Its use, for example in chronic inflammatory response syndrome, is largely off-label and not supported by strong controlled trials. Evidence for specific protocols is limited.